Nonprofit agency says Spark's gene therapy $425K price tag is too high

Spark said the analysis is faulty because it excludes indirect costs associated with vision loss.

Source: bizjournals.com Health Care:Biotechnology headlines - January 16, 2018 Category: Biotechnology Authors: John George Source Type: news